HER-2阳性胃癌:当前的向治疗方法
Rama Rao Malla1, Haasita Reddy Nellipudi2, Mundla Srilatha3
1Cancer Biology Laboratory, Department of Biochemistry and Bioinformatics, Institute of Science, Gandhi Institute of Technology and Management (Deemed to be University), Visakhapatnam, AP 530045, India.
International journal of biological macromolecules
|June 21, 2024
概括
人类表皮生长因子受体2 (HER2) 放大驱动胃癌 (GC) 转移和耐药性. 针对HER2的新疗法,包括植物化学品和纳米颗粒,显示出改善患者治疗结果的希望.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是一种高度转移的疾病,通常以人体表皮生长因子受体2 (HER2) 放大为特征.
- 异常的HER2表达与GC中转移的增加,治疗耐药性和瘤复发有关.
- 激素HER2放大促进药物耐药性,通过调高DNA修复酶和药物排泄蛋白等机制.
研究的目的:
- 审查HER2介导机制和GC中信号通路的最新进展.
- 探索HER2作为胃癌中可向的驱动器的作用.
- 讨论 HER2 阳性 GC 的辅助疗法的临床前研究.
主要方法:
- 关于在GC中HER2介导机制的近期进展的文献综述.
- 分析受HER2影响的上游和下游信号通路.
- 检查对trastuzumab敏感剂的临床前研究.
主要成果:
- HER2放大有助于GC的进展和对治疗的抵抗.
- HER2 影响癌症干细胞特性和瘤源信号传递.
- 临床前研究表明植物化学品,化疗药物和纳米颗粒作为辅助疗法的潜力.
结论:
- 在HER2阳性GC中,HER2是关键的向性驱动因素.
- 针对HER2的辅助疗法有望提高治疗疗效.
- 需要进一步的研究和临床试验,以加强对HER2阳性GC的治疗.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Peptic Ulcer Disease IV: Management
87
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
87
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
358
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
358
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Cancer Vaccines
352
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
352


